Research articlePublished 3 Nov 2022
Metabolism Study of Fluor-Nitrophenylallylideneindolinone Ligand: A Radioimaging Agent for False Folded Alpha-Synuclein in the Diagnosis of Parkinson's Disease by High-Performance Liquid Chromatography and Tandem Mass Spectrometry
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: The false folded protein of alpha (α) synuclein forms aggregation and causes neurodegenerative diseases known as α-synucleinopathies, such as Parkinson's disease. A radioactive fluor- labeled ligand, (Z)-{(fluoroethoxy) ethyl}-(E)-3-(4-nitrophenyl)-allylidene]-indolin-2-one (αsyn-18F), was synthesized and tested as a Positron Emission Tomography (PET) imaging agent for use in animal studies for the diagnosis of α-synucleinopathies. Aim: To assess the synthetic products qualities of α-syn-F standard and its precursor, α-syn-Ms (Ms: methanesulfonate), determine the attendant impurities, and metabolites of α-syn-F in plasma, liver and brain biosystems. Methods: Various sample solutions were analyzed via High-Performance Liquid Chromatography (HPLC) on a C18 column, with the identities determined via electrospray ionization-triple quardupole tandem mass spectrometry. Results: The purities of α-syn-F and α-syn-Ms were both better than 94% with the major impurities being intermediate product residuals. The analytical method for tracing impurities in α-syn-F was applied to study the metabolites in various biomatrices, including rat liver microsomes, mice plasma, and liver and brain homogenate solutions. Here, seven, four, ten, and six metabolites were identified in the four biomatrices, respectively. Conclusion: Biotransformation occurs in fluoroethoxyethyl, which results in the truncation and oxidation of the side chain and hydroxylation at the nitrophenylallylideneindolinone group before sulfonation, methylation, and glycine conjugation. A number of these metabolites lost their fluor and were not more traceable on the PET graph. The results suggest that PET imaging should be finalized within 30 min after intravenous administration of α-syn-F into the body.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Longdom does not store it.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Drug Metabolism & Toxicology
- SubjectDiabetes & Endocrinology
- SubjectPharmaceutical Sciences
- SubjectToxicology
- BylineArticles whose byline prints “Weihsi Chen”
- BylineArticles whose byline prints “Kuanyin Chen”
- BylineArticles whose byline prints “Tsungyu Shih”
- BylineArticles whose byline prints “Siaosyun Guan”
- BylineArticles whose byline prints “Shioushiow Farn”
